Maitreya Medicare Ltd (NSE SME)
Oct 27, 2023 - Nov 1, 2023
| Price | ₹78 - ₹82 |
| Premium | ₹75 |
|---|---|
| Lot size | 1600 |
| Allotment | Nov 3, 2023 |
| Listing | Nov 7, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 1600 | 131200 | 382 |
| HNI | 2 | 3200 | 262400 | 170 |
Last updated on 01-Nov-2023 17:22:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 3,29,600 | 2,81,52,000 | 85.41 |
| NIB | 2,72,000 | 20,24,84,800 | 744.43 |
| RETAIL | 6,11,200 | 31,13,42,400 | 509.4 |
| Total | 12,12,800 | 54,19,79,200 | 446.88 |
| Retail Apps | 1,94,589 | © IPO Premium | |
Incorporated in 2019, Maitreya Medicare Limited is a multispeciality hospital situated in Surat, Gujrat. The main focus of the hospital is multi-disciplinary integrated healthcare services, with primary secondary & tertiary care. Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.
As of 2023, the hospital has a 125-bed capacity under the leadership of Dr. Narendra Singh Tanwar, founder, Promoter, CFO, and Managing Director of the hospital, Dr Pranav Rohitbhai Thaker, Promoter & whole-time director, and Mr. Vimal Patel, Promoter & Whole Time Director.
Maitreya Medicare Limited IPO Details
| Issue Size | 1,816,000 shares (aggregating up to ₹[.] Cr) |
| Fresh Issue | 1,816,000 shares (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 4,960,000 |
| Share holding post issue | 6,776,000 |
| Market Maker portion | 108,800 shares Giriraj Stock Broking |
Maitreya Medicare Limited IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | < 50% of the Net Issue |
| Retail Shares Offered | > 35% of the Net Issue |
| NII (HNI) Shares Offered | > 15% of the Net Issue |
Company Financials
Maitreya Medicare Limited Financial Information (Restated Consolidated)
Maitreya Medicare Limited's revenue decreased by -19.69% and profit after tax (PAT) rose by 271.95% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period | 30 Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
| Assets | 3,122.31 | 2,749.89 | 2,448.79 | 2,527.23 |
| Revenue | 2,484.51 | 3,994.91 | 4,974.41 | 5,704.44 |
| Profit | 254.05 | 422.65 | 113.63 | 424.34 |
| Net Worth | 1,118.31 | 864.26 | 471.11 | 386.22 |
| Reserves | ||||
| Borrowing | 520.21 | 585.12 | 750.25 | 919.05 |
| Amount in ₹ Lakhs | ||||
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: maitreyamedicare.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html